PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
RS Marketinsights

Press Release


Receive press releases from RS Marketinsights: By Email RSS Feeds:

Versatile Innovation in Oncology


With 6,484 active product developments in the pharmaceutical industry, Oncology is the largest therapy area pipeline by a considerable margin.

Indore, India, November 26, 2015 --(PR.com)-- Indore, M.P., India – With 6,484 active product developments in the pharmaceutical industry, Oncology is the largest therapy area pipeline by a considerable margin.

RS MarketInsights, a leading provider of detailed market research reports, is now offering an in-depth research report on versatile innovation in oncology therapy. This report will help you understand the current clinical and commercial development of oncology indication.

Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of cancer. It comprises a huge and diverse range of indications and stages, encompassing virtually all sites and tissues in the human body. By the increasing number of death due to cancer in economically developed and developing countries, the oncology pipeline is now considered as the largest among any other therapy areas. In oncology development, across all the indications and stages, there are total 6,484 and 2,084 active products. With the maximum number of product development, oncology is growing commercially on a high scale.

Due to the underlying pathophysiology, there are a large number of crossovers between oncology indications. As a result, it is common for all the products being developed to undergo a developmental programs testing them across multiple indications. Around 473 first-in-class pipeline products are in simultaneous development for two or more of the top twenty cancer sites ranked by their prevalence. The most versatile first-in-class molecular targets consist of receptor tyrosine kinases as well as their downstream signal transduction kinases. Although some of the other cancer-related processes such as cancer immunosurveillance and apoptotic pathways are also targeted.

About the Company:

This resource had been provided by RS MarketInsights. RS MarketInsights is one of the leading distributors of market research reports in the world today. They produce business intelligence reports that help companies to device the strategies. They provide market insights and research data for various fields like Aerospace &Defense, Biotechnology, Healthcare & Medical Devices, Pharmaceuticals, Energy & Natural Resources, Manufacturing and Automation Industry, Telecom& IT industries, etc.
Contact Information
RS Marketinsights
Salil Modak
+91-9893555190
Contact
http://www.rsmarketinsights.com/
#255, Lokmanya Nagar
Indore – 452009, Madhya Pradesh, India
Phone: US Toll Free: +1 888-789-6604,
+91-9893555190

Click here to view the list of recent Press Releases from RS Marketinsights
Promote Your Business